T4	Tissue 76 83	macular
T8	Tissue 222 229	macular
T10	Drug_or_compound 574 585	fluorescein
T11	Organism_subdivision 809 813	head
T1000	Organism 280 288	patients
T1001	Organism 498 506	patients
T1002	Organism 599 607	Patients
T1003	Organism 669 677	patients
T1004	Organism 864 872	patients
T1005	Organism 877 882	women
T1006	Organism 887 890	men
T1007	Organism 1006 1014	patients
T1008	Organism 1184 1192	patients
T1009	Organism 1287 1295	patients
T1010	Organism 1397 1405	patients
T1011	Organism 1647 1655	Patients
T2	Blood_vessel_development 42 60	neovascularization
T6	Blood_vessel_development 181 199	neovascularization
T9	Blood_vessel_development 522 540	neovascularization
T3	Breakdown 84 96	degeneration
E3	Breakdown:T3 Theme:T4
T7	Breakdown 230 242	degeneration
E7	Breakdown:T7 Theme:T8
T1	Regulation 137 144	Control
E1	Regulation:T1 Theme:E13
T5	Planned_process 618 625	treated
E2	Planned_process:T5 Theme:T1002
T12	Planned_process 678 686	received
E4	Planned_process:T12 Theme:T1003
T13	Planned_process 1025 1032	therapy
E5	Planned_process:T13 Theme:T1007
T14	Planned_process 1357 1367	irradiated
E6	Planned_process:T14 Theme:T1010
T15	Planned_process 1387 1396	untreated
E8	Planned_process:T15 Theme:T1010
A1	Negation E8
T16	Planned_process 1276 1286	irradiated
E9	Planned_process:T16 Theme:T1009
T17	Negative_regulation 1203 1211	refusing
E10	Negative_regulation:T17 Theme:E11
T18	Planned_process 1212 1224	radiotherapy
E11	Planned_process:T18 Theme:T1008
E12	Blood_vessel_development:T2 
E13	Blood_vessel_development:T6 
E14	Blood_vessel_development:T9 
